As the hype surrounding cannabis legalization in Canada continues to simmer down, one major bank has pulled the plug on allowing investors to short cannabis stocks.

The Bank of Montreal (BMO) (NYSE:BMO,TSX:BMO) runs a self-directed brokerage called InvestorLine. According to a report from the Financial Post, a number of investors have recently been turned down when trying to open short positions on cannabis stocks.


BMO supposedly told these investors that shorting simply will not be possible for any cannabis stock.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The marijuana stock market has seen its fair share of volatile periods, and short positions have risen as bets against dominating stocks in the space increase.

Shorting a stock is an investment strategy in which an investor or a trader places a bet that a particular company’s share price will drop.

Investopedia describes the action of short selling as when “a position is opened by borrowing shares of a stock or other asset that the investor believes will decrease in value by a set future date — expiration date. The investor then sells these borrowed shares to buyers willing to pay the market price.”

According to the investors who spoke with BMO, they were denied the ability to short cannabis stocks due to market volatility. The move from the bank seems to be recent, with one investor stating that they had opened a short position on CannTrust Holdings (NYSE:CTST,TSX:TRST) through InvestorLine in July.

Other major banks such as the Toronto-Dominion Bank (NYSE:TD,TSX:TD), the National Bank of Canada (TSX:NA,OTC Pink:NTIOF) and the Canadian Imperial Bank of Commerce (NYSE:CM,TSX:CM) remain free of restrictions on cannabis stocks.

EditedOne of the favorites for short sellers has been Tilray (NASDAQ:TLRY), a cannabis producer that has seen one of the most volatile performances since its initial public offering in July 2018.

According to S3 Partners, short sellers of cannabis stocks have had a tough year, but recently have experienced some significant gains.

“Short selling is fairly concentrated to a handful of names, with the top 20 shorts making up over 85 (percent) of the total shorting executed in the sector,” Ihor Dusaniwsky, managing director of predictive analytics at S3 Partners, wrote in a report.

At the Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) Cannabis Business Conference in Vancouver earlier this year, Neal Gilmer, equity research analyst with Haywood Securities, told investors that the prominence of short sellers may be attributed to the high interest the sector has seen with its rampant growth.

Canadian cannabis companies Cronos Group (NASDAQ:CRON,TSX:CRON) and Aphria (NYSE:APHA,TSX:APHA) have faced public short seller attacks from investment research groups as well.

With files from Bryan Mc Govern.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

First Units on Sale Today at Newburgh Dispensary with Availability Tomorrow at Carle Place , Forest Hills , and Plattsburgh Locations

With Enough Product to Supply Wholesale Partners by Month’s End

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day.

Keep reading... Show less

Cannabis legalization in Canada brought the promise of global business opportunities, but it also led to missed potential in research on the medical side. 

Even before the days of adult-use legalization in Canada, the market had seen a barrage-like cycle of ups and downs, creating uncertainty about where to find solid investment opportunities.

Keep reading... Show less

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming events hosted by Microdose:

  • Psychedelic Capital to be held virtually on Thursday, October 28, 2021 . Payton Nyquvest , Founder and CEO of Numinus, will present at 1:45 p.m. ET . To attend, please register here .
  • Wonderland: Miami to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 8-9, 2021 . Mr. Nyquvest and Dr. Evan Lewis , Founder & Director of the Neurology Centre of Toronto , will give a presentation called Psychedelic Neurology in the Treatment of Trauma on Monday, November 8 at 4:40 p.m. ET . In addition, Sharan Sidhu , Science Officer & General Manager of Numinus, will participate in the Patent Wars panel on Tuesday, November 9 at 4:30 p.m. ET . To attend, please register here .

For more information about the events or to schedule a one-on-one meeting with Numinus‘ management, please contact KCSA Strategic Communications at NuminusIR@kcsa.com .

Keep reading... Show less

Florida’s leading cannabis company to open three new Miami dispensaries

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), the largest multi-state operator (MSO) in the United States today announced the reopening of three medical marijuana dispensaries in Miami, Florida . The locations were formerly branded as Harvest House of Cannabis.

Keep reading... Show less